Jeffrey T. Hajibandeh, D.D.S., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Orbital Fractures | 3 | 2023 | 110 | 2.330 |
Why?
|
Orbital Implants | 2 | 2022 | 21 | 1.670 |
Why?
|
Surgery, Oral | 2 | 2022 | 146 | 1.180 |
Why?
|
Maxillofacial Injuries | 1 | 2023 | 33 | 0.910 |
Why?
|
Mandibular Fractures | 3 | 2022 | 73 | 0.590 |
Why?
|
Orbit | 3 | 2023 | 426 | 0.500 |
Why?
|
Palatal Neoplasms | 1 | 2014 | 35 | 0.480 |
Why?
|
Surgery, Computer-Assisted | 1 | 2022 | 1018 | 0.480 |
Why?
|
Palate, Soft | 1 | 2014 | 96 | 0.460 |
Why?
|
Lymphoma, AIDS-Related | 1 | 2014 | 84 | 0.450 |
Why?
|
Dental Implants | 1 | 2021 | 749 | 0.450 |
Why?
|
Checklist | 1 | 2017 | 830 | 0.360 |
Why?
|
Medical Errors | 1 | 2017 | 1297 | 0.330 |
Why?
|
Immunocompromised Host | 1 | 2014 | 847 | 0.320 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2014 | 1378 | 0.230 |
Why?
|
Trauma Centers | 3 | 2023 | 889 | 0.220 |
Why?
|
Facial Injuries | 1 | 2023 | 183 | 0.200 |
Why?
|
Temporomandibular Joint Disorders | 1 | 2020 | 215 | 0.150 |
Why?
|
Workflow | 1 | 2021 | 847 | 0.140 |
Why?
|
Patient Transfer | 1 | 2022 | 761 | 0.130 |
Why?
|
Periodontium | 1 | 2014 | 99 | 0.120 |
Why?
|
Wounds and Injuries | 1 | 2023 | 2400 | 0.090 |
Why?
|
Vitamin B Complex | 1 | 2010 | 288 | 0.080 |
Why?
|
Retrospective Studies | 7 | 2023 | 77426 | 0.070 |
Why?
|
Tissue Scaffolds | 1 | 2014 | 956 | 0.070 |
Why?
|
Quality Assurance, Health Care | 1 | 2017 | 2211 | 0.070 |
Why?
|
Emergency Service, Hospital | 2 | 2022 | 7659 | 0.070 |
Why?
|
Humans | 15 | 2023 | 744220 | 0.070 |
Why?
|
Telemedicine | 1 | 2023 | 2872 | 0.070 |
Why?
|
Mouth Neoplasms | 1 | 2010 | 601 | 0.060 |
Why?
|
Regeneration | 1 | 2014 | 1485 | 0.060 |
Why?
|
Folic Acid | 1 | 2010 | 1300 | 0.060 |
Why?
|
Tissue Engineering | 1 | 2014 | 1880 | 0.060 |
Why?
|
Facial Bones | 1 | 2022 | 201 | 0.050 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2010 | 2948 | 0.040 |
Why?
|
Temporomandibular Joint | 1 | 2020 | 196 | 0.040 |
Why?
|
Young Adult | 2 | 2023 | 56436 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 12961 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20123 | 0.040 |
Why?
|
Length of Stay | 2 | 2022 | 6308 | 0.040 |
Why?
|
Dietary Supplements | 1 | 2010 | 3297 | 0.040 |
Why?
|
United States | 3 | 2022 | 69867 | 0.040 |
Why?
|
Adolescent | 2 | 2023 | 85759 | 0.040 |
Why?
|
Face | 1 | 2022 | 994 | 0.040 |
Why?
|
Triage | 1 | 2023 | 976 | 0.030 |
Why?
|
Quality Improvement | 2 | 2021 | 3746 | 0.030 |
Why?
|
Middle Aged | 2 | 2023 | 213367 | 0.030 |
Why?
|
Child | 1 | 2023 | 77679 | 0.030 |
Why?
|
Postoperative Complications | 3 | 2022 | 15294 | 0.030 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2010 | 4033 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2010 | 10480 | 0.030 |
Why?
|
Amelogenin | 1 | 2014 | 15 | 0.030 |
Why?
|
Connective Tissue Growth Factor | 1 | 2014 | 96 | 0.030 |
Why?
|
Dental Pulp | 1 | 2014 | 82 | 0.030 |
Why?
|
Calcification, Physiologic | 1 | 2014 | 169 | 0.030 |
Why?
|
Outpatients | 1 | 2021 | 1486 | 0.030 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2014 | 350 | 0.030 |
Why?
|
Adult | 2 | 2023 | 214035 | 0.020 |
Why?
|
Risk Factors | 3 | 2022 | 72280 | 0.020 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2010 | 284 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8343 | 0.020 |
Why?
|
Patient Readmission | 1 | 2021 | 3114 | 0.020 |
Why?
|
HIV Infections | 1 | 2014 | 16718 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2014 | 13036 | 0.020 |
Why?
|
Logistic Models | 1 | 2021 | 13409 | 0.020 |
Why?
|
Collagen | 1 | 2014 | 2689 | 0.020 |
Why?
|
Phenotype | 2 | 2014 | 16365 | 0.020 |
Why?
|
Stem Cells | 1 | 2014 | 3567 | 0.010 |
Why?
|
Risk Assessment | 1 | 2021 | 23337 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2010 | 4328 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2010 | 10949 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2014 | 19227 | 0.010 |
Why?
|
Cell Line | 1 | 2010 | 15999 | 0.010 |
Why?
|
Male | 1 | 2014 | 350027 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2022 | 63119 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2010 | 16687 | 0.010 |
Why?
|
Aged | 1 | 2022 | 163253 | 0.010 |
Why?
|
Mice | 1 | 2014 | 81178 | 0.000 |
Why?
|
Animals | 1 | 2014 | 168788 | 0.000 |
Why?
|